| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| HAMILTON THORNE Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 390,55 | -1,95 % | BMO bekräftigt Einstufung für Intuitive Surgical angesichts des Wachstumspotenzials bei ambulanten OP-Zentren | ||
| UNITEDHEALTH | 352,60 | -5,92 % | Elizabeth Warren Targets CVS, UnitedHealth and Cigna, Says Healthcare Giants 'Take a Cut at Every Step' as She Calls for Breaking Up Conglomerates | ||
| MEDTRONIC | 93,14 | -0,49 % | Medtronic: What Happens When Healthcare Technology Starts With People | From living rooms to operating rooms, human-centered design is informing the future of tech?Key takeawaysHuman-centered design at Medtronic uses patient, caregiver, and clinician insights to make medical... ► Artikel lesen | |
| TELADOC HEALTH | 7,612 | -4,08 % | Teladoc Health, Inc.: Teladoc Health Expands Comprehensive Weight Care Program with Employer Contribution Option for GLP-1 Medications | ||
| SERNOVA BIOTHERAPEUTICS | 0,067 | +1,52 % | Sernova Biotherapeutics: 11,2 Millionen für die Fusion - BetaNova rückt näher | ||
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences GAAP EPS of $0.00, revenue of $4.63M | ||
| HCA HEALTHCARE | 454,30 | -2,22 % | Nach der US-Wahl: Diese Aktien werden jetzt zu Gewinnern - deutsche Konzerne dabei | © Foto: wO-GeminiDer Wahlsieg der Demokraten verändert die Spielregeln an der Börse. Solaraktien schießen nach oben, auch Europas Industrie hofft auf Entlastung. Welche Unternehmen kurz- und langfristig... ► Artikel lesen | |
| LANTHEUS | 92,40 | -0,11 % | Lantheus Holdings, Inc.: Lantheus Presents Data from Two Pivotal Phase 3 Studies of TAUKLARIFY (Florquinitau F 18 Injection) PET Imaging in Early Alzheimer's Disease | ||
| CAREDX | 67,00 | -0,74 % | CareDx is a new Overweight at Piper Sandler on transplant testing opportunity | ||
| ENVISTA | 21,400 | -1,83 % | Here's Why You Should Retain NVST Stock in Your Portfolio for Now | ||
| GT BIOPHARMA | 3,150 | -10,89 % | GT Biopharma reports Q3 results | ||
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results |
Reports Record Fiscal Year Net Income of $2.8 Million, 14% YoY B2B ARR Increase and ARR of $22.5 Million
HENDERSON, Nev., Sept. 9, 2026 /PRNewswire/ -- Research... ► Artikel lesen | |
| CARMAT | - | - | CARMAT SAS: EFICAS Study Results Confirm the Clinical Performance of the Aeson Total Artificial Heart as a Bridge-to-Transplant Therapy | The study's primary endpoint was achieved in 72.7% of the 55 patients implanted between December 2022 and May 2025.
This rate was significantly above the historical benchmark of 38% established... ► Artikel lesen | |
| CHEMOMETEC | 92,40 | -0,43 % | Chemometec A/S: Major shareholder announcement - BlackRock, Inc. |